Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Brodsky: Durable treatment-free remission after high-dose cyclophosphamide therapy for previously.... (0.05 sec) 

Durable treatment-free remission after high-dose cyclophosphamide therapy for previously …

- annals.org [PDF] 
RA Brodsky, LL Sensenbrenner, BD Smith, D … - Annals of internal medicine, 2001 - Am Coll Physicians
Background: Severe aplastic anemia is a life-threatening bone marrow failure
disorder. High-dose cyclophosphamide therapy fol- lowed by allogeneic bone
marrow transplantation cures the dis- ease. However, it requires a suitable ...
Cited by 66 - Related articles - BL Direct - All 9 versions

High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial


JF Tisdale, DE Dunn, N Geller, M Plante, O … - The Lancet, 2000 - Elsevier
Between June, 1997, and March, 2000, 31 patients were enrolled. 15 were assigned
cyclophosphamide (1 h intravenous infusion of 50 mg/kg daily for 4 days) and 16
were assigned ATG (40 mg/kg daily for 4 days); both groups received ...
Cited by 71 - Related articles - BL Direct - All 5 versions

High-dose cyclophosphamide as salvage therapy for severe aplastic anemia


RA Brodsky, AR Chen, I Brodsky, RJ Jones - Experimental hematology, 2004 - Elsevier
At median follow-up of 29 months, 10 patients (59%) are alive. Nine patients
(53%) achieved a drug-free remission after high-dose cyclophosphamide; 4
patients achieved a complete remission and 5 patients currently meet ...
Cited by 41 - Related articles - All 7 versions

Complete remission in severe aplastic anemia after high-dose cyclophosphamide without …

- hematologylibrary.org [PDF] 
RA Brodsky, LL Sensenbrenner, RJ Jones - Blood, 1996 - bloodjournal.hematologylibrary.org
. reserved Hematology; all rights Copyright 2007 by The American Society of
Suite 200, Washington DC 20036. semimonthly by the American Society of
Hematology, 1900 M St, NW, Blood (print ISSN 0006-4971, online ISSN ...
Cited by 119 - Related articles - BL Direct - All 7 versions

Late complications following treatment for severe aplastic anemia (SAA) with high-dose …

- hematologylibrary.org
JF Tisdale, JP Maciejewski, O Nunez, SJ … - Blood, 2002 - bloodjournal.hematologylibrary.org
Immunosuppression with antithymocyte globulin (ATG) and cyclosporine (CSA)
results in long-term survival in patients with severe aplastic anemia (SAA),
comparable to that achieved by allogeneic bone marrow transplantation from ...
Cited by 33 - Related articles - BL Direct - All 7 versions

Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating …


E Di Bona, F Rodeghiero, B Bruno, A Gabbas, P … - British journal of haematology, 1999 - interscience.wiley.com
About 30% of patients with severe aplastic anaemia (SAA) unresponsive to one
course of immunosuppressive (IS) therapy with antithymocyte or antilymphocyte
globulin can achieve complete or partial remission after a second IS ...
Cited by 64 - Related articles - BL Direct - All 3 versions

Relapse of aplastic anaemia after immunosuppressive treatment: a report from the …


H Schrezenmeier, P Marin, A Raghavachar, S … - British Journal of Haernatology, 1993 - interscience.wiley.com
SummaryThis study was designed to determine the incidence of relapse and factors
predictive for relapse in 719 patients with severe aplastic anaemia (SAA) after
immunosuppressive treatment (IS). Patients developing myelodysplasia or ...
Cited by 78 - Related articles - BL Direct - All 3 versions

High dose cyclophosphamide for severe refractory myasthenia gravis

- bmj.com [PDF] 
DE Gladstone, TH Brannagan III, RJ … - British Medical Journal, 2004 - jnnp.bmj.com
Emotion processing in the minimally conscious state As a newly described
condition distinct from coma or the vegetative state, minimally conscious state
(MCS) is characterised by a threshold level of consciousness, and diag- ...
Cited by 16 - Related articles - BL Direct - All 7 versions

Late clonal diseases of treated aplastic anemia


G Socié, S Rosenfeld, N Frickhofen, E … - Seminars in hematology, 2000 - Elsevier
Recent progress in the treatment of aplastic anemia has dramatically changed the
previously grim prognosis for these patients. Improvements in bone marrow
transplantation and immunosuppression have increased the number of ...
Cited by 95 - Related articles - BL Direct - All 7 versions

Treatment of refractory myasthenia:“rebooting” with high-dose cyclophosphamide


DB Drachman, RJ Jones, RA Brodsky - Annals of neurology, 2003 - interscience.wiley.com
Patients with myasthenia gravis (MG) who do not respond to conventional
immunotherapeutic agents, or cannot tolerate their side effects, are considered
refractory. Ablation of the immune system followed by bone marrow ...
Cited by 71 - Related articles - BL Direct - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google